Total Utang marang Modal ZimVie (ZIMV)

ZimVie Inc. (ZIMV) - logo korporat

ZimVie Inc. production capacities are operating at maximum efficiency while undergoing technical modernization. The leverage ratio—total debt to equity—on the GURU.Markets historical chart reflects debt dynamics, where 0.55 determines the current value of the metric. Management aims to optimize the portfolio to drive profit growth, yet high debt leverage and pressure from insurers remain key risks for the business.

ZIMV: Rasio Utang marang Ekuitas zimvie.com 28.04.2023 - 01.11.2025

Rincian analitis perusahaan ZimVie Inc.

- rega lan prakiraan konsensus rega:
Bagan rega ZimVie|ZIMV - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar ZimVie|ZIMV - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham ZimVie|ZIMV - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku zimvie.com|ZIMV - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal ZimVie Inc.|ZIMV - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal ZimVie Inc.|ZIMV - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ZimVie|ZIMV - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan ZimVie|Rasio cepet zimvie.com
- informasi bathi lan kelipatan valuasi:
ZIMV - Asil keuangan resik
Analisis dhasar perusahaan:ZIMV, ZimVie
Produk dadi ZimVie Corp

The total debt-to-equity ratio determines the extent of a business's financial dependence on borrowed funds relative to its own resources. By analyzing changes in the total debt-to-equity level, an investor assesses the balance between leverage and financial stability. This metric compares total liabilities with shareholder equity to identify default risks. For ZimVie Inc. (ZIMV), moderate leverage is justified by stable demand for implants. High clinic loyalty ensures a predictable cash flow for debt servicing.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal angiodynamics.com ANGO|Cerus (CERS) - Utang marang Ekuitas|Rasio Utang marang Ekuitas TKNO|Utang marang Ekuitas Monogram Technologies Inc|Sharps Tech (STSS) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas INFU (InfuSystem Holdings)|Utang Agregat marang Modal UTMD|Utang marang Ekuitas KORU Medical KRMD|Rasio Kabeh Utang marang Dana Pribadi NYXH|MBOT: Rasio Total Utang marang Ekuitas|PDEX - Total Utang marang Modal|Zentek Ltd. (ZTEK) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas elutia.com|MLSS (Milestone Scientific Inc.) - Total Utang marang Modal|Utang marang Modal NEXGEL Inc. NXGL|Utang marang Ekuitas Retractable Technologies (RVP)|harvardbioscience.com - Rasio Utang marang Ekuitas|Femasys Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal MHUA (Meihua Medical Technologies)|POAI - Utang marang Ekuitas|Koefisien Total Utang marang Modal Callan JMB Inc CJMB|ATRI (Atrion Corp) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Ekuitas NURO (NeuroMetrix Corporation)